Featured on September 2023 Featured Report
More from September 2023 Featured Report
Oct 18, 2024
Letter urges FTC to block Novo’s $16.5bn Catalent purchase
How and why AstraZeneca’s oncology eyes turned to cell therapies
CDMO AGC places CO plant on ice amid turbulent CGT economy
AtomVie partners with Radiopharm Ventures to produce radioantibody for trials